Investor: The direction of mobile medicine is right, but not yet.

This year, Gobi partner Zhu Yu has been focusing on software and hardware integration opportunities, and has cast several companies from the hardware perspective to provide programs to improve their lives, including intelligent thermometers that monitor body temperature for pregnant women and children. He told the first financial daily that he was interested in mobile medical programs that involved chronic blood sugar, blood pressure, or physical data that recorded heartbeat and fitness. For this kind of project, Zhu Yu's idea is, "now although the business model is not clear, income is not clear, but it does not matter, as long as there is a clear trend of the vote we will." ”

This is the common idea of most investors. After the early development of technology, mobile phones and other intelligent terminals, the health care industry has become a mobile communications industry to find another ideal of the combination, and the entire capital market is also aimed at this direction to try to blow this typhoon mouth under a group of pigs want to fly up.

The 2013 China Medical Internet Development Report, released by China Medical and Materials Association, showed that the market size of China Mobile's health care in 2013 reached 2.34 billion, an increase of 25.8% over the previous year. It is expected that by the end of 2017, China Mobile medical market will exceed tens of billions of dollars to reach 12.53 billion yuan.

There is no doubt that the market outlook has further strengthened the belief of the investment institutions, and since last year, the enthusiasm for mobile health investment has been rising. Reporters recently interviewed a number of investment agencies, almost all of the respondents said mobile medical care is its focus on an important investment direction.

According to the Chingko Research Center statistics, from 2010 to 2014 March, the mobile medical industry has a total of 58 investment events, involving 33 enterprises, the disclosure amount of more than 100 million U.S. dollars.

The lively surface

At this stage, mobile medicine according to product form can be divided into two categories, one is based on app application of various types of online services, the other is the main "software + hardware" mode, hardware provides accurate data monitoring, supporting software is focused on data analysis results after the user experience. The former with the spring Rain handheld doctor, quick to ask a doctor, 5U family doctor, master Health and other enterprises as the representative, the latter is the main indicator of human body monitoring products, such as monitoring blood sugar sugar nurses, blood pressure monitoring Kankan blood pressure and other enterprises. Investors are already on the back of both types of businesses.

The case of companies being chased by investment institutions and the industry being chased by capital seems to be a common understanding of the mobile medical industry. However, the fact is not as good as the ideal. Chunghwa Capital China Vice President Yang Junbiao told reporters that mobile medicine in the country is a new concept, and at this stage in foreign countries can draw on the enterprise or model is not many, mature projects are scarce.

In the Mobile medical field for a long time watching the DFJ fund management partner Li Guangxin also told reporters that mobile internet in some industries is actually a means of cross-border integration, mobile medicine is a clear example. "The most recent combination with mobile medicine is wearable equipment, which has to do with mobile internet, big data, and cloud computing, but all of this is going to fall, not just the resources on the wire," he said. "To this end, although many projects have been seen, but DFJ has not yet a mobile medical field of investment cases."

"From last year to now, investment agencies have not been thinking about what they really want to look for in the mobile medical enterprise." "An entrepreneur in a mobile medical industry who has been doing a round of financing for a while, told reporters since mobile medicine spans a wide range of industries, including healthcare, health management, and TMT, he has been exposed to various types of investment agencies, and almost every family has simply put mobile medicine into a single industry.

"The most I have to do is to invest in TMT, and they are used to looking at mobile medical programs on the internet, requiring rapid growth to be the first." "Because we still have hardware, investors are most worried about whether we will spend all the money on the hardware, contrary to their traditional idea of investing in light assets," added the entrepreneur. ”

In addition, the founders also said that in their contacts with investors, they also worry about how the hardware products to attract consumers after the market. "They will ask the user's retention rate is high, user activity will be consumed within a few months, the user's acquisition costs, and so on, and even suggest that we want to lay the market Foundation." ”

Search for a profit model

At present, the concept of the mobile medical field is still in the vague stage and the investment is misgivings, but this is not a unilateral reason.

"Many mobile medical enterprises have not yet had a more mature profit model, if the investment funds can not achieve a benign recovery, the future mobile medical care will be difficult to continue to hot." Li, analyst at the Institute of Investment and Research, said.

In his view, most of the current domestic mobile medical enterprises are still in the initial stage of user accumulation, for example, the market is more hot consumption-type medical concept equipment, which is concentrated in some simple data monitoring and recording, such as blood pressure and blood sugar and other equipment, for the lack of depth of data mining, customer interaction between poor, and other medical interaction platform and community, the profit is mainly through the transfer of advertising fees, intermediary fees, value-added services and online interrogation to achieve.

Yang Junbiao also told reporters that most mobile medical enterprises are still in the accumulation of user-laying stage, through the collection and use of data, its profit model grafting in advertising fees, intermediary fees, value-added services and online interrogation, such as the initial business model of the exploration stage.

"The current situation is that mobile medicine has not yet come to the stage of industry explosion, investors feel that this direction is right, but in the specific how to judge on some of the handle is not allowed, so there are many institutions to take a wait and see cautious attitude, but also have deep pockets of the peers will blindly hit the money, afraid of the hands of a few years before the heat, Missed this wave of mobile medicine. An investor who declined to be named told reporters bluntly.

Although the profit model has not yet fully matured, but since last year, there have been investment agencies in the field of investment in the sector from the beginning of the hundreds of thousands of U.S. dollars jumped to tens of millions of dollars, and the current single hardware products can be hundreds of millions of dollars in the record also makes many peers in the sense that not understand the same time more difficult to start.

But a notable trend in mobile medicine is that companies that have previously featured software services are trying to find access through hardware, while many already have hardware-based businesses looking for exports to graft data.

With the rise of wearable technology, the combination of mobile medical software and hardware will bring about the explosive growth of the market, meanwhile, the combination of software and hardware can effectively help the mobile medical enterprises to find the profit model. "Li that at present Epocrates, Cardionet, WellDoc, ZocDoc, Vocera and other companies have been successful in the field of mobile medicine, the future of mobile medical concepts and wearable equipment will be the organic combination of new investment outbreak point.

(Responsible editor: Mengyishan)